Oral Ferrous Sulfate 325mg Daily for Hemoglobin 7.6 g/dL
For a patient with hemoglobin 7.6 g/dL and suspected iron deficiency, oral ferrous sulfate 325mg once daily is appropriate as first-line therapy, but you must simultaneously assess for severe symptoms or circulatory compromise that would require transfusion or intravenous iron. 1
Initial Assessment and Treatment Decision
With hemoglobin 7.6 g/dL, this patient has moderately severe anemia. The critical first step is determining whether they have:
- Severe symptoms: dyspnea at rest, chest pain, altered mental status, syncope
- Circulatory compromise: tachycardia >100 bpm at rest, hypotension, signs of heart failure
- Unstable coronary artery disease
If any of these are present, consider restricted packed red cell transfusion (target Hb 70-90 g/dL, or 80-100 g/dL with coronary disease) followed by iron replacement 1. Transfusion alone will not replenish iron stores—each unit contains only ~200mg elemental iron 1.
Oral Iron as First-Line Therapy
If the patient is hemodynamically stable and not severely symptomatic, oral ferrous sulfate 325mg once daily (providing 65mg elemental iron) is the appropriate initial treatment. 1, 2
Optimal Dosing Strategy
The most recent guidelines (2024 and 2021) recommend:
- 50-100mg elemental iron once daily taken on an empty stomach 3, 1
- Ferrous sulfate 325mg provides 65mg elemental iron—within the ideal range 2
- No benefit to dosing more than once daily: hepcidin levels remain elevated for 48 hours after iron intake, blocking further absorption 3
- Taking iron 2-3 times daily increases side effects without improving absorption 3
Administration Instructions
For maximum absorption:
- Take in the morning on an empty stomach 1
- With 100mg vitamin C (or a glass of orange juice) to enhance absorption 3
- Avoid tea, coffee, calcium supplements, antacids, or PPIs within 1 hour 3
- If GI side effects occur, taking with food is acceptable but reduces absorption 3
Monitoring and Expected Response
Critical monitoring at 2 weeks:
- Hemoglobin should increase by ≥1 g/dL within 2 weeks 3, 1
- Absence of ≥1 g/dL rise has 90.1% sensitivity for predicting treatment failure 1
If hemoglobin fails to rise ≥1 g/dL at 2 weeks, switch to intravenous iron 3, 1
Continue monitoring hemoglobin every 4 weeks until normalized, then continue oral iron for 2-3 months after normalization to replenish stores 1.
When to Use Intravenous Iron Instead
Consider IV iron as initial therapy (rather than oral) if the patient has:
- Post-bariatric surgery anatomy
- Active inflammatory bowel disease
- Chronic kidney disease or heart failure
- Ongoing blood loss exceeding oral iron absorption capacity
- Previous documented intolerance to oral iron
- Severe ID requiring rapid correction 3
Common Pitfalls to Avoid
Don't prescribe 325mg twice or three times daily: The FDA label suggests 2-3 times daily 2, but this is outdated. Current evidence shows once-daily dosing is equally effective with fewer side effects 3, 1
Don't defer treatment while awaiting diagnostic workup unless colonoscopy is imminent 1
Don't forget to investigate the underlying cause: With Hb 7.6 g/dL, evaluate for GI blood loss, menstrual losses in premenopausal women, malabsorption (celiac disease, H. pylori, atrophic gastritis), or dietary insufficiency 3
Don't assume oral iron failure without checking adherence and absorption: Common causes of treatment failure include non-compliance, malabsorption, ongoing bleeding, concurrent B12/folate deficiency, or systemic disease 1
Alternative Dosing if Side Effects Occur
If the patient develops nausea, constipation, or abdominal pain on daily dosing:
- Reduce to 325mg every other day (alternate-day dosing improves tolerance and may enhance fractional absorption, though total iron delivery is slower) 3, 1
- Consider ferric maltol or other formulations, though no evidence supports superiority of one ferrous salt over another 3
- Do not switch between ferrous sulfate, fumarate, and gluconate—no evidence this helps 1